KR20040032821A - 아데노신 트리포스페이트의 투여를 통한 근육 피로의 감소방법 - Google Patents

아데노신 트리포스페이트의 투여를 통한 근육 피로의 감소방법 Download PDF

Info

Publication number
KR20040032821A
KR20040032821A KR10-2003-7015913A KR20037015913A KR20040032821A KR 20040032821 A KR20040032821 A KR 20040032821A KR 20037015913 A KR20037015913 A KR 20037015913A KR 20040032821 A KR20040032821 A KR 20040032821A
Authority
KR
South Korea
Prior art keywords
atp
composition
amount
coating
gastric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR10-2003-7015913A
Other languages
English (en)
Korean (ko)
Inventor
스티브 에스. 리
리차드 비. 하인슨
조 조우
Original Assignee
테크니컬 소싱 인터내셔널, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 테크니컬 소싱 인터내셔널, 인크. filed Critical 테크니컬 소싱 인터내셔널, 인크.
Publication of KR20040032821A publication Critical patent/KR20040032821A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR10-2003-7015913A 2001-06-04 2002-06-04 아데노신 트리포스페이트의 투여를 통한 근육 피로의 감소방법 Withdrawn KR20040032821A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US29570501P 2001-06-04 2001-06-04
US60/295,705 2001-06-04
US10/162,143 2002-06-03
US10/162,143 US20030069203A1 (en) 2001-06-04 2002-06-03 Method for increasing human performance by reducing muscle fatigue and recovery time through oral administration of adenosine triphosphate
PCT/US2002/017835 WO2002098226A1 (en) 2001-06-04 2002-06-04 Method for reducing muscle fatigue through administration of adenosine triphosphate

Publications (1)

Publication Number Publication Date
KR20040032821A true KR20040032821A (ko) 2004-04-17

Family

ID=26858483

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2003-7015913A Withdrawn KR20040032821A (ko) 2001-06-04 2002-06-04 아데노신 트리포스페이트의 투여를 통한 근육 피로의 감소방법

Country Status (6)

Country Link
US (1) US20030069203A1 (https=)
EP (1) EP1406495A1 (https=)
JP (1) JP2004535417A (https=)
KR (1) KR20040032821A (https=)
CA (1) CA2449712A1 (https=)
WO (1) WO2002098226A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210078540A1 (en) * 2019-09-17 2021-03-18 GM Global Technology Operations LLC Track-guided wiper system and method

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101184496A (zh) * 2005-05-27 2008-05-21 兴和株式会社 用于恢复疲劳的药品
US20070203091A1 (en) * 2006-02-28 2007-08-30 Eliezer Rapaport Methods and therapeutic compositions for improving liver, blood flow and skeletal muscle functions in advanced diseases and aging
WO2007132718A1 (ja) * 2006-05-12 2007-11-22 Kowa Company, Ltd. アデノシン５´三リン酸又は生理学的に許容されるその塩を含有する固形製剤
TW200812601A (en) * 2006-05-30 2008-03-16 Kowa Co Medicine for recovering from fatigue
WO2008001494A1 (en) * 2006-06-27 2008-01-03 Kowa Co., Ltd. Pharmaceutical agent for prevention of fatigue and/or recovery from fatigue

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3819830A (en) * 1971-07-01 1974-06-25 Dainippon Pharmaceutical Co Method for treating diseases by coenzyme a and adenosine triphosphate and composition therefor
JPH0696534B2 (ja) * 1986-04-25 1994-11-30 ヘキストジヤパン株式会社 抗痴呆剤
US4871718A (en) * 1987-12-29 1989-10-03 Raymond A. Roncari Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair
JPH01308232A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 固型医薬およびその製造法
JPH01308231A (ja) * 1988-06-03 1989-12-12 Takeda Chem Ind Ltd 安定化された医薬組成物および製造法
GB9724813D0 (en) * 1997-11-25 1998-01-21 Univ Nottingham Reducing muscle fatigue
US5973005A (en) * 1998-02-26 1999-10-26 Bio-Bontanica, Inc. Aqueous creatine solution and process of producing a stable, bioavailable aqueous creatine solution
AU8028600A (en) * 1999-10-20 2001-04-30 Eliezer Rapaport Methods, pharmaceutical and therapeutic compositions for administering adenosine
US6723737B1 (en) * 1999-10-20 2004-04-20 Eliezer Rapaport Methods, pharmaceutical and therapeutic compostions for administering adenosine
US6399116B1 (en) * 2000-04-28 2002-06-04 Rulin Xiu Rhodiola and used thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210078540A1 (en) * 2019-09-17 2021-03-18 GM Global Technology Operations LLC Track-guided wiper system and method

Also Published As

Publication number Publication date
CA2449712A1 (en) 2002-12-12
US20030069203A1 (en) 2003-04-10
WO2002098226A1 (en) 2002-12-12
EP1406495A1 (en) 2004-04-14
JP2004535417A (ja) 2004-11-25
WO2002098226B1 (en) 2003-03-20

Similar Documents

Publication Publication Date Title
CN111050764A (zh) β-羟基丁酸酯和丁二醇的S对映异构体及其使用方法
US20070265343A1 (en) Method for alleviating signs and symptoms of spasticity
WO2012142413A2 (en) Nitrite compositions and uses thereof
US11344556B2 (en) Appetite suppressant compositions and methods thereof
IE59066B1 (en) Controlled release potassium chloride
JP2017505325A (ja) 亜鉛プロトポルフィリンの微粒子送達のための製剤
US7629329B2 (en) Method for increasing muscle mass and strength through administration of adenosine triphosphate
JPH07330584A (ja) 疲労改善剤
WO2002020090A9 (en) Pharmaceutical compositions
KR20090021288A (ko) 피로 예방 및/또는 회복을 위한 의약
KR20040032821A (ko) 아데노신 트리포스페이트의 투여를 통한 근육 피로의 감소방법
US20060062849A1 (en) Oral formulation of creatine derivatives and method of manufacturing same
KR101741281B1 (ko) 건선 치료를 위한 ａ3 아데노신 수용체 작동약 (ｉｂ-ｍｅｃａ/ｃｆ-101)을 포함하는 제약학적 조성물
CN110225767B (zh) 细胞内atp增强剂
CA3074541C (en) Appetite suppressant compositions and methods thereof
EP4025579B1 (en) Compositions containing adenosine triphosphate (atp) and methods of use
JPH07330593A (ja) 疲労改善剤
WO2001012200A1 (en) An oral composition comprising coenzyme a for treating hyperlipemia, the preparation method and the use thereof
KR20190046675A (ko) 간질환 예방 또는 치료용 의약 조성물
US20070065511A1 (en) Controlled delivery creatine formulations and method of using the same
TW202313072A (zh) 檸檬酸鐵之兒科調配物
US20060062853A1 (en) Treating neuromuscular disorders with an oral formulation of creatine derivatives
KR20220084098A (ko) 분산성 연장 방출형 조성물 및 그를 제조하기 위한 공정
JP5114394B2 (ja) 疲労回復のための医薬
EP1221945A1 (en) Methods, pharmaceutical and therapeutic compositions for administering adenosine

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20031204

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid